Four enzymes, selected as representative of major metabolic pathways (malic dehydrogenase, of the citric acid cycle, lactic dehydrogenase, of glycolysis, glucose-6-phosphate dehydrogenase, of the pentose pathway and glutamic dehydrogenase, of glutamate metabolism), were measured by quantitative histochemical methods in individual hypothalamic nuclei of adult neonatally androgenized female rats. Malic dehydrogenase (MDH) was significantly reduced in nuclei of the anterior hypothalamus: the suprachiasmatic, supraoptic and anterior. Lactic dehydrogenase (LDH) increased significantly in the lateral preoptic area. Glucose-6-phosphate dehydrogenase G-6-PDH was also significantly elevated in anterior hypothalamic nuclei: medial preoptic, lateral preoptic, supraoptic and paraventricular. Glutamic dehydrogenase (GDH) was generally elevated throughout the hypothalamus with significant increases of activity occurring in the paraventricular, lateral ventromedial, arcuate, medial mamillary and posterior nuclei.
Three control point enzymes of the Embden-Meyerhof pathway, hexokinase (HK), phosphofructokinase (PFK) and pyruvate kinase (PK), have been measured in individual hypothalamic nuclei during the 5-day estrous cycle of adult rats by quantitative histochemical methods. PK levels, low during proestrus, rise to maximum activity during estrus; this rise is significantly greater than on all other days of the cycle in the lateral preoptic area (LP), ventromedial pars medialis (VMM) and pars lateralis (VML) and posterior hypothalamic (Post) nuclei. HK activity also rises from low proestrous levels during the cycle but, in contrast to PK, reaches maximum activity during diestrus-1 (D-l) or diestrus-2 (D-2). PFK showed variable changes during the estrous cycle with peaks occurring during estrus in some nuclei and during diestrus in others, but these changes were not significantly different. These metabolic changes occur in specific hypothalamic nuclei which have been shown by electrical stimulation, lesion production, stereotaxic hormone implantation and localization of luteinizing hormone-releasing factor experiments to have an important role in reproductive physiology and sexual behavior.
Three enzymes selected as representative of major metabolic pathways (malic dehydrogenase, of the citric acid cycle, lactic dehydrogenase, of glycolysis and glucose-6-phosphate dehydrogenase, of the pentose pathway) were measured by quantitative histochemical methods in individual hypothalamic nuclei during the 5-day estrous cycle of adult rats. Malic dehydrogenase increases significantly from low proestrous levels to a peak at estrus and then declines during diestrus in the following nuclei and areas of the anterior hypothalamus: medial and lateral preoptic, suprachiasmatic, supraoptic, and anterior. Significant peaks of lactic dehydrogenase occur more often during diestrus-3 in hypothalamic nuclei of the middle and posterior hypothalamus. Glucose-6-ρhosphate dehydrogenase has a biphasic pattern with peaks usually occurring during the diestrous period.
Three control point enzymes of the Embden-Meyerhof pathway, hexokinase (HK), phosphofructokinase (PFK) and pyruvate kinase (PK) were measured by quantitative histochemical methods in individual hypothalamic nuclei of adult neonatally androgenized female rats. HK activity was significantly increased in anterior hypothalamic nuclei: medial preoptic, lateral preoptic, and suprachiasmatic. PK was significantly elevated in the lateral preoptic and suprachiasmatic nuclei of the anterior hypothalamus and also in the medial mamillary nucleus and median eminence. No significant changes occurred in PFK activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.